These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 23866711)
21. [Uveitis. A status assessment]. Arocker-Mettinger E; Grabner G Fortschr Ophthalmol; 1990; 87 Suppl():S110-7. PubMed ID: 2083890 [TBL] [Abstract][Full Text] [Related]
22. New developments in corticosteroid therapy for uveitis. Taylor SR; Isa H; Joshi L; Lightman S Ophthalmologica; 2010; 224 Suppl 1():46-53. PubMed ID: 20714181 [TBL] [Abstract][Full Text] [Related]
24. Plasmid electrotransfer of eye ciliary muscle: principles and therapeutic efficacy using hTNF-alpha soluble receptor in uveitis. Bloquel C; Bejjani R; Bigey P; Bedioui F; Doat M; BenEzra D; Scherman D; Behar-Cohen F FASEB J; 2006 Feb; 20(2):389-91. PubMed ID: 16352651 [TBL] [Abstract][Full Text] [Related]
25. [Recent advances in clinical and basic studies of uveitis in China in the last five years]. Yang PZ; Xing L Zhonghua Yan Ke Za Zhi; 2005 Aug; 41(8):743-7. PubMed ID: 16191333 [TBL] [Abstract][Full Text] [Related]
27. Light on the horizont: biologicals in Behçet uveitis. Hazirolan D; Stübiger N; Pleyer U Acta Ophthalmol; 2013 Jun; 91(4):297-306. PubMed ID: 22520021 [TBL] [Abstract][Full Text] [Related]
28. Recent developments in the treatment of posterior uveitis. Suttorp-Schulten MS; Jager MJ; Kijlstra A Ocul Immunol Inflamm; 1996; 4(4):207-17. PubMed ID: 22827460 [TBL] [Abstract][Full Text] [Related]
29. Uveitis: Mechanisms and recent advances in therapy. Srivastava A; Rajappa M; Kaur J Clin Chim Acta; 2010 Sep; 411(17-18):1165-71. PubMed ID: 20416287 [TBL] [Abstract][Full Text] [Related]
30. Type I interferons as immunoregulatory molecules; implications for therapy in experimental autoimmune uveoretinitis. Mizuguchi J; Takeuchi M; Usui M Arch Immunol Ther Exp (Warsz); 2002; 50(4):243-54. PubMed ID: 12371620 [TBL] [Abstract][Full Text] [Related]
32. Mycobacterial ocular inflammation: delay in diagnosis and other factors impacting morbidity. Patel SS; Saraiya NV; Tessler HH; Goldstein DA JAMA Ophthalmol; 2013 Jun; 131(6):752-8. PubMed ID: 23579549 [TBL] [Abstract][Full Text] [Related]
33. Moving forward in uveitis therapy: preclinical to phase II clinical trial drug development. Salazar-Méndez R; Yilmaz T; Cordero-Coma M Expert Opin Investig Drugs; 2016; 25(2):195-214. PubMed ID: 26640977 [TBL] [Abstract][Full Text] [Related]
34. [Uveitis research 1963-1993. 1993 Bruppach Lecture of the Zurich University]. Martenet AC Klin Monbl Augenheilkd; 1994 Jul; 205(1):3-13. PubMed ID: 7933906 [TBL] [Abstract][Full Text] [Related]
35. [Climate therapy of uveitis in a mountain environment]. Cepilová Z; Porubská M; Slámová J Cesk Oftalmol; 1993 Apr; 49(2):90-4. PubMed ID: 8490974 [TBL] [Abstract][Full Text] [Related]
36. Gene therapy methods in bone and joint disorders. Evaluation of the adeno-associated virus vector in experimental models of articular cartilage disorders, periprosthetic osteolysis and bone healing. Ulrich-Vinther M Acta Orthop Suppl; 2007 Apr; 78(325):1-64. PubMed ID: 17427340 [TBL] [Abstract][Full Text] [Related]